SB 906·WV·senate
Permitting lawful prescription of crystalline polymorph psilocybin under FDA recommendations
Signed into LawFiled Feb 10, 2026
Sponsor: Vince Deeds (R)
Latest Action
S Chapter 249, Acts, Regular Session, 2026
Jun 25, 2026
Summary
The bill amends West Virginia’s controlled‑substance statutes to let doctors legally prescribe, distribute, and market crystalline polymorph psilocybin once the FDA approves it and the DEA moves it out of Schedule I. It gives the State Board of Pharmacy authority to recommend schedule changes and act on emergencies, while keeping the existing Schedule I list otherwise unchanged. The law took effect 90 days after being signed in March 2026.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SB 906 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 906 freeOr ask your AI assistant about SB 906 directly:
Add to Claude, ChatGPT or Cursor